Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mohammad Ali Judaki"'
Autor:
Mehdi Mohammadi, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Mohammad Arjmand, Tannaz Bahadori, Mohammad Ali Judaki, Fariba Shiravi, Hengameh Ahmadi Zare, Farzaneh Notash Haghighat, Maryam Mobini, Mohammad Mehdi Amiri, Fazel Shokri
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Overexpression of HER2 has been reported in many types of cancer, making it a perfect candidate for targeted immunotherapy. The combination of two FDA approved monoclonal antibodies (mAbs), trastuzumab and pertuzumab, has more robust anti-tumor activ
Externí odkaz:
https://doaj.org/article/3e424d89f2fd4f8d8f3b89a35ab7dbe6
Autor:
Alireza Namazi, Abolfazl Khedive, Shiva Ghamari, Mohammad Ali Judaki, Esmaeil Saberfar, Seyed Moayed Alavian, Reza Malekzadeh, Mehdi Norouzi, Masoud Ziaee, Azam Ghaziasadi, Ramin Rahimnia, Seyed Mohammad Jazayeri
Publikováno v:
Acta Medica Iranica, Vol 50, Iss 4, Pp 265-272 (2012)
This study was designed to determine the correlation of hepatitis B virus surface Ag (HBsAg) variations with the clinical/serological pictures among chronic HBsAg positive patients. The surface gene (S-gene) was amplified and directly sequenced in tw
Externí odkaz:
https://doaj.org/article/0b80b742573f4ff0b91671c2ef61b594
Autor:
Azam Ghaziasadi, Masoud Ziaee, Mehdi Norouzi, Reza Malekzadeh, Seyed Moayed Alavian, Esmaeil Saberfar, Mohammad Ali Judaki, Shiva Ghamari, Abolfazl Khedive, Alireza Namazi, Ramin Rahimnia, Seyed Mohammad Jazayeri
Publikováno v:
Acta Medica Iranica, Vol 50, Iss 4 (2012)
This study was designed to determine the correlation of hepatitis B virus surface Ag (HBsAg) variations with the clinical/serological pictures among chronic HBsAg positive patients. The surface gene (S-gene) was amplified and directly sequenced in tw
Externí odkaz:
https://doaj.org/article/6156e467a6be4cb2a286f26282b468e2
Autor:
Mehdi Norouzi, Seyed Ali Ghorashi, Behrooz Ataei, Majid Yaran, Reza Malekzadeh, Seyed Moayyed Alavian, Mohammad Ali Judaki, Shiva Ghamari, Alireza Namazi, Ramin Rahimnia, Abolfazl Khedive, Seyed Mohammad Jazayeri
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 13, Iss 47 (2010)
Objective(s)The aim of this study was to characterize the hepatitis B virus surface protein genotypes and sequence variations among hepatitis B virus surface antigen (HBsAg) positive chronic patients in Hormozgan province, south of Iran.Materials and
Externí odkaz:
https://doaj.org/article/b35b32fdf0e542608996ea9c29a42cd4
Autor:
Mehdi Mohammadi, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Mohammad Arjmand, Fatemeh Torkashvand, Tannaz Bahadori, Mohammad Ali Judaki, Fariba Shiravi, Hengameh Ahmadi Zare, Farzaneh Notash Haghighat, Maryam Mobini, Fazel Shokri, Mohammad Mehdi Amiri
Publikováno v:
Journal of Immunotherapy. 46:121-131
Autor:
Masoud Hassanzadeh Makoui, Maryam Mobini, Jalal Khoshnoodi, Mohammad Ali Judaki, Tannaz Bahadori, Hengameh Ahmadi Zare, Forough Golsaz-Shirazi, Hediyeh Moradi Tabriz, Zahra Madjd, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani, Mohammad Mehdi Amiri, Fazel Shokri
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 23(9)
Estrogen and progesterone regulate the growth and development of several human cells and tissues. Their corresponding receptors (ER and PR) are important diagnostic and prognostic indicators for cancers of the breast and reproductive organs. Immunohi
Autor:
Mehdi Mohammadi, Maryam Mobini, Danesh Hassani, Parisa Yousefi, Fazel Shokri, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Mohammad Ali Judaki
Publikováno v:
Current research in translational medicine. 69(2)
Background The human epidermal growth factor receptor (HER/ErbB) family-targeted therapies result in a significant improvement in cancer immunotherapy. Monoclonal antibodies (MAb) against HER2 demonstrated a survival benefit for patients; however, dr
Autor:
Farzaneh Notash Haghighat, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Fazel Shokri, Forough Fatemi, Hengameh Ahmadi Zare, Maryam Mobini, Fariba Shiravi, Mehdi Mohammadi, Mohammad Mehdi Amiri, Tannaz Bahadori, Mohammad Ali Judaki
Publikováno v:
Investigational new drugs. 39(3)
Immunotherapy of HER2-overexpressing cancers by FDA approved monoclonal antibodies (mAbs) such as trastuzumab and pertuzumab has shown promising results. We have recently produced a novel humanized anti-HER2 mAb, hersintuzumab, which did not sterical
Autor:
Roya Khosravi-Eghbal, Masoumeh Douraghi, Mohammad Hossein Kazemi, Vahid Salimi, Mahmood Jeddi-Tehrani, Fazel Shokri, Sara Abdolmaleki, Maryam Golara, Peyman Bakhshaei, Mohammad Ali Judaki, Jalal Khoshnoodi
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 38(4)
Vaccination with whole-cell or acellular (Ac) vaccines has been very effective for the control of pertussis. The immune response to Ac vaccines has been generally associated with a shift toward the Th2 profile. In the present study, overlapping recom
Autor:
M. A. Pourhosseingholi, Behrooz Ataei, Masood Ziaee, Zeinab Fazeli, Shiva Ghamari, Mehdi Saberifiroozi, Hossein Keyvani, Ebrahim Kalantari, Hadi Karimzadeh, Fatemeh Ramezani, Azim Nejatizadeh, Seyed Mohammad Jazayeri, Fariborz Mansour-Ghanaei, Vahdat Poortahmasebi, Babak Sayad, Mehdi Norouzi, Zahra Goodarzi, Maryam Daram, Houshang Rafatpanah, Majid Yaran, Mohammad-Hossein Somi, Reza Malekzadeh, Ismail Sanei-Moghaddam, Seyed Moayed Alavian, Ghodratollah Montazeri, M. Mahabadi, Gholamreza Sarizadeh, Mohammad Ali Judaki, Abolfazl Khedive, Farshid Abedi
Publikováno v:
Journal of Viral Hepatitis. 20:494-501
Mutations within the coding region of hepatitis B surface antigen (HBsAg) have been found naturally in chronic carriers. To characterize the mutations of HBsAg from Iranian chronic carriers who were vaccine and/or medication naive. The surface genes